Tuberculosis (TB) is one of the leading causes of death due to its being an infectious
disease, caused by the airborne pathogen Mycobacterium tuberculosis (M. tb) …

Objectives The aim of the study was to update the classification of drugs used in multidrug-
resistant tuberculosis (MDR-TB) regimens. Group A drugs (fluoroquinolones, bedaquiline …

Background Antimicrobial resistance (AMR) poses a significant global health threat, and an
accurate prediction of bacterial resistance patterns is critical for effective treatment and …

Global tuberculosis (TB) eradication is undermined by increasing prevalence of emerging
resistance to available drugs, fuelling ongoing demand for more complex diagnostic and …

Drug-resistant (DR) tuberculosis (TB) is a major public health concern globally, complicating
TB control and management efforts. West Africa has historically faced difficulty in combating …

Introduction Despite recent advances in diagnostic technologies and new drugs becoming
available, tuberculosis (TB) remains a major global health burden. If detected early …

Background Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a
global health threat, necessitating faster and more accessible diagnostic methods. This …

Background Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is one of the
top infectious killer diseases in the world. The emergence of drug-resistant MTB strains has …

A rapid and comprehensive drug susceptibility test is essential for eliminating drug resistant
tuberculosis. Next generation sequencing (NGS) based susceptibility testing is being …

Tuberculosis remains a persistent global health challenge, demanding swift and accurate
diagnostic methods for effective treatment. The emergence of the Xpert MTB/RIF Ultra …